Latest / Bloomberg Intelligence / What's Next For Netflix? Look Ahead To Earnings
Transcript
- 0:00Speaker 1: Welcome to the Bloomberg Markets Podcast. I'm Paul Sweeney alongside
- 0:04Speaker 1: my co host Matt Miller. Every business day, we bring
- 0:06Speaker 1: you interviews from CEOs, market pros, and Bloomberg experts, along
- 0:11Speaker 1: with essential market moving news. Find the Bloomberg Markets Podcast
- 0:15Speaker 1: on Apple Podcasts or wherever you listen to podcasts, and
- 0:18Speaker 1: at Bloomberg dot com slash podcast. Let's keep on that
- 0:22Speaker 1: Netflix team, shall we. They report earnings next week, and
- 0:26Speaker 1: that's usually a big event for the stock. Let's welcome
- 0:29Speaker 1: uh keitha wrong Onah and she is the technology and
- 0:31Speaker 1: media annalyst at Bloomberg Intelligence. She's been covering this company
- 0:35Speaker 1: pretty much since its inception as a public company. Keithan,
- 0:38Speaker 1: thanks so much for joining us here. What can we expect?
- 0:41Speaker 1: What are investors really looking for when Netflix reports next week? Yeah,
- 0:46Speaker 1: thank you so much Paul and Taylor for inviting me
- 0:50Speaker 1: to this conversation. So, um, it's going to be a
- 0:53Speaker 1: pretty week quarter for Netflix. They have telegraphs that pretty
- 0:57Speaker 1: well to investors, so they're expecting about one million editions.
- 1:02Speaker 1: This will be the lowest ever for the company in
- 1:05Speaker 1: at least ten years, and really it's a factor of
- 1:08Speaker 1: many different things. So you had that massive pull forward
- 1:11Speaker 1: of demand from last year because of COVID when they
- 1:14Speaker 1: reported twenty six million subscribers in the first half of
- 1:18Speaker 1: that's usually the number that they report for the whole year.
- 1:21Speaker 1: And then you also have, now, you know, the the
- 1:24Speaker 1: additional factor of people going wanting to go more outdoors
- 1:27Speaker 1: and demanding more out of home entertainment. And then the
- 1:30Speaker 1: third thing that we're seeing is that there was obviously
- 1:33Speaker 1: the effect of all those production shutdowns, so they had
- 1:36Speaker 1: a pretty light content slate into Q, none of their
- 1:40Speaker 1: big titles, So it's really the impact of all those
- 1:43Speaker 1: three and so a pretty weak quarter is what we're
- 1:45Speaker 1: expecting in general. With that weak quarter that we're expecting,
- 1:50Speaker 1: it seems like Netflix is trying to get ahead of
- 1:52Speaker 1: that announcement and help engagement and help penetration by going
- 1:56Speaker 1: into video games. What can we expect from net fille
- 2:00Speaker 1: Alla video games? Yeah, I think that's you know, it's
- 2:04Speaker 1: it's kind of been in the offering, I think for
- 2:06Speaker 1: a little while now, and I think it's really a
- 2:09Speaker 1: very natural extension of their content strategy. I think what
- 2:13Speaker 1: they're trying to do is to really be a comprehensive
- 2:16Speaker 1: entertainment solution and really trying to build more and more
- 2:19Speaker 1: engagement as you pointed out, and really more time spent
- 2:22Speaker 1: with the platform. Remember a few years ago, when you know,
- 2:25Speaker 1: read Hingston's was asked about who their biggest competitor competitor is.
- 2:29Speaker 1: He didn't say an Amazon Prime or or even Hbo.
- 2:33Speaker 1: He he pointed out Fortnite as being their biggest competitor
- 2:36Speaker 1: for time and attention. Um, so that's really kind of
- 2:39Speaker 1: what they want. They want to you know, increase engagement,
- 2:41Speaker 1: they want to increase time spent. And I think it's
- 2:44Speaker 1: it really kind of makes sense that it makes it.
- 2:46Speaker 1: It's a huge oportnity for Netflix to be able to
- 2:48Speaker 1: differentiate its content offering, boost subscriber engagement, boost retention against
- 2:53Speaker 1: all the other streaming players. Keithan talked to us about
- 2:57Speaker 1: the competitive environment again. Over the last year, you know,
- 3:00Speaker 1: we saw a lot of new players on the streaming business,
- 3:03Speaker 1: you know, Disney Plus and Peacock and you know all
- 3:06Speaker 1: the others uh that are out there. Give us a
- 3:09Speaker 1: sense of how it's shaking out in these early quarters. So, Um,
- 3:14Speaker 1: as you pointed out, Paul, I mean, Disney Plus has
- 3:17Speaker 1: been a runaway hit, so they have amassed more than
- 3:20Speaker 1: hundred million subscribers in you know, just a very short
- 3:24Speaker 1: about just about thirteen to fourteen months, so they it's
- 3:27Speaker 1: been a blockbuster success for them. Um and of course,
- 3:31Speaker 1: as you pointed out, we've had a lot of new
- 3:32Speaker 1: players kind of a burst down into the screen. But
- 3:35Speaker 1: I think we're kind of seeing, uh, really this come
- 3:39Speaker 1: emerged as as as a two horse race, if you will,
- 3:42Speaker 1: between Netflix and Disney, but you're also seeing all the
- 3:45Speaker 1: other players kind of trying to jockey for scale. So
- 3:47Speaker 1: Amazon time very big deals just in the space of
- 3:51Speaker 1: you know, the past few weeks. They went out and
- 3:53Speaker 1: acquired the NFL Thursday Night games for about eleven to
- 3:57Speaker 1: twelve billion dollars and then the NBM studio for another
- 4:01Speaker 1: eight and a house dollars. So again they really want
- 4:03Speaker 1: to make Prime a talk to your service. Then you
- 4:06Speaker 1: then you have HBO Max and the Discovery deal creating
- 4:09Speaker 1: a new company, a hundred and fifty billion dollar company.
- 4:11Speaker 1: Again HBO Max wanting to kind of break into that uh,
- 4:15Speaker 1: top tier streaming offering. So we're definitely going to see
- 4:18Speaker 1: a shakeout. I think at the end of the day,
- 4:20Speaker 1: we're probably going to see about three or four or
- 4:23Speaker 1: five major services Nextlork, Mestics, and Disney and Amazon obviously
- 4:27Speaker 1: the top one to three I think among those, and
- 4:30Speaker 1: then it's going to be really interesting to see what
- 4:32Speaker 1: happens with you know, speak of what happens with viacoms,
- 4:35Speaker 1: Paramount plus. I think eventually consolidation is on the card,
- 4:41Speaker 1: but we'll have to wait and watch. There seems to
- 4:43Speaker 1: be a push pull. We feel like there has to
- 4:45Speaker 1: be consolidation because you have to be big to compete.
- 4:49Speaker 1: And yeah, we're getting a lot of big anti trust,
- 4:52Speaker 1: anti big tech rhetoric out of this administration, saying that
- 4:56Speaker 1: they don't like big companies. They want to promote competition.
- 5:00Speaker 1: Do you expect deals to get done and and do
- 5:03Speaker 1: they get done or they can be tied up in
- 5:06Speaker 1: courts for a while. Yeah, So even with the that's
- 5:09Speaker 1: a great point. I think even with the Amazon deal,
- 5:12Speaker 1: I mean we have the new you know, FTC chair
- 5:14Speaker 1: who kind of expressed some reservations about that. But I
- 5:16Speaker 1: don't think they're necessarily if you kind of just look
- 5:19Speaker 1: at the business that you know, any of these big
- 5:21Speaker 1: tech players are in, I don't think they necessarily pose
- 5:25Speaker 1: any competitive challenges right Acquiring a studio acquiring a media company. Um. Again,
- 5:30Speaker 1: I'm not really sure about how long it could be
- 5:33Speaker 1: tied up in courts, but I think ultimately, um, you know,
- 5:36Speaker 1: if tex players like an Apple or an Amazon wants
- 5:38Speaker 1: to go on studio, I think they should be able
- 5:40Speaker 1: to do so without too much hassle. Keith A real
- 5:43Speaker 1: quick thirty seconds. Is Netflix still a subscriber growth story?
- 5:46Speaker 1: I see the stocks flat year to date. Um, so
- 5:50Speaker 1: they have done a really good job, Paul, and kind
- 5:52Speaker 1: of moving away a little bit from that over focus
- 5:55Speaker 1: on subscribers. They're really now focusing more on free cash
- 5:57Speaker 1: flows on margins, and they're showing some real, really good
- 6:01Speaker 1: numbers on that front as well. All right, Keithan, thank
- 6:04Speaker 1: you so much for joining us. As always, you are
- 6:06Speaker 1: our guru for all things t MT. Keith Wrong and Nothing,
- 6:10Speaker 1: technology and media analyst for Bloomberg Intelligence joining us on
- 6:13Speaker 1: the phone from New Jersey. Uh. I hired Githa back
- 6:17Speaker 1: in the day. We worked together for ten days or
- 6:19Speaker 1: ten years, and she has just developed into one of
- 6:21Speaker 1: the top media and now technology analysts on Wall Street.
- 6:24Speaker 1: And we're fortunate to have her and all the other
- 6:26Speaker 1: good folks at a Bloomberg intelligence. Let's talk about retail sales.
- 6:34Speaker 1: Got some numbers this morning. Came in better than expected.
- 6:38Speaker 1: Retail sales came into zero point six percent gain versus
- 6:41Speaker 1: a forecast of a zero point three decline. So pretty
- 6:44Speaker 1: strong there. Let's get some details on that and some
- 6:45Speaker 1: of the other retail issues out there in the U
- 6:48Speaker 1: S consumer. We do that with A. G. Solanki, national
- 6:51Speaker 1: director for Retail in the US for Collier's International, joins
- 6:54Speaker 1: us on the zone from phone from San Francisco and Chie,
- 6:57Speaker 1: thanks so much for taking the time, love to get
- 6:59Speaker 1: your kind of foot snapshot on the US consumer right
- 7:04Speaker 1: here as we slowly come out on the other side
- 7:06Speaker 1: of this pandemic. Yeah, thanks for having me. So let's
- 7:10Speaker 1: just just dive in. So what we're seeing right now
- 7:12Speaker 1: is definitely we saw certain categories in retail I e. Clothing, uh,
- 7:18Speaker 1: certain F and B categories, department store sales drop anywhere between,
- 7:26Speaker 1: and of course conversely, we saw the e commerce jump in.
- 7:29Speaker 1: Right now, we're starting to see a shift. People are
- 7:32Speaker 1: definitely coming back strong as it relates to buying power
- 7:36Speaker 1: in store, and with that, we're starting to see in
- 7:40Speaker 1: certain sectors a rebound. For example, in apparel increase. It's
- 7:45Speaker 1: the largest increase we've seen thus far in any category.
- 7:49Speaker 1: And also in addition to that, we're starting to see
- 7:52Speaker 1: um store expansion. So this is led by the grocery,
- 7:56Speaker 1: the home, beauty, and value oriented concepts. So new store
- 8:01Speaker 1: openings right now or outpacing store closing, so we're pretty
- 8:04Speaker 1: excited about that. How are consumers feeling about paying higher prices?
- 8:10Speaker 1: On one hand, you have retail sales that looked relatively
- 8:15Speaker 1: strong today, but then you're seeing consumer sentiment fall because
- 8:19Speaker 1: inflation expectations in the next year are expected to be
- 8:22Speaker 1: the highest since two thousand and eight. Are they willing
- 8:25Speaker 1: to pay these higher prices? So there is definitely a
- 8:30Speaker 1: concern around that, I think because there's this um you know,
- 8:33Speaker 1: kind of the stimulus payment of starting to slowly fade away,
- 8:36Speaker 1: so they haven't really put a percent of their mindset
- 8:38Speaker 1: into Hey, we're looking at inflation of some sort and pricing,
- 8:43Speaker 1: so there's still a spend, a strong spend, and what
- 8:46Speaker 1: we're seeing from that strong spend occur is in what
- 8:49Speaker 1: I would say more the service oriented side. So going
- 8:54Speaker 1: to the getting a massage, going for a pedigure, mannic here,
- 8:58Speaker 1: getting your hair done, um, the hair salons, et cetera.
- 9:01Speaker 1: So we're still seeing that momentum um. When we I
- 9:05Speaker 1: think it will start to fade, maybe we'll probably see
- 9:07Speaker 1: those results closer to Q three Q four. So Andie,
- 9:11Speaker 1: one of the things we saw from this from the
- 9:13Speaker 1: retail perspective during this pandemic is what a lot of
- 9:16Speaker 1: folks are saying is just you know, this accelerating growth
- 9:18Speaker 1: of e commerce, and maybe it might have pulled maybe
- 9:21Speaker 1: two or three years worth of market share gains in
- 9:23Speaker 1: terms of e commerce in terms of relative to total
- 9:25Speaker 1: re retail sales, maybe poured it, pulled it forward maybe
- 9:28Speaker 1: by two or three years. Is that in fact the case?
- 9:31Speaker 1: And do you think some of those e commerce gains
- 9:32Speaker 1: are here to stay? Um? I don't do not believe
- 9:37Speaker 1: they are here to stay. I think they are a
- 9:39Speaker 1: part of our shopping journey for any UM consumer. However,
- 9:43Speaker 1: what we're starting to see is a bit of a
- 9:45Speaker 1: cutback as it relates to e commerce, and our Q
- 9:49Speaker 1: two numbers that we're forecasting are roughly around thirteen point
- 9:52Speaker 1: six percent compared to Q two so UM, granted, it
- 9:56Speaker 1: was kind of an off quarter, but nonetheless we're starting
- 9:59Speaker 1: to see a stay realization, and I think that people
- 10:02Speaker 1: are still there's still you know, when we look at
- 10:04Speaker 1: the square footage in terms of UM per person square
- 10:08Speaker 1: footage of retail, it's still pretty significant. People want to
- 10:11Speaker 1: be out there. Are we finding enough workers to come
- 10:17Speaker 1: back to work? Good question. Yeah, that's that's a great question. Honestly,
- 10:22Speaker 1: it's been a big struggle some quick things that we've
- 10:25Speaker 1: been hearing, especially with chain restaurants and fast casual. What
- 10:29Speaker 1: we're seeing in that, you know, in that area is
- 10:32Speaker 1: that it has been a struggle. So what are they doing? Well,
- 10:35Speaker 1: they've identified some interesting ways to get around it. First off,
- 10:38Speaker 1: we're seeing a lot of the chain restaurants being quite
- 10:41Speaker 1: creative with how they're approaching or how they're getting out
- 10:44Speaker 1: there to identifying new employees. So we're not seeing too
- 10:48Speaker 1: much of an overpaying or arise in wages, but we're
- 10:52Speaker 1: seeing some interesting things of how they're kind of connecting
- 10:54Speaker 1: with you know this you know, the employees um and
- 10:59Speaker 1: that's either through TikTok. So a lot of the brands
- 11:02Speaker 1: are starting to use TikTok to um really get the
- 11:05Speaker 1: brand awareness out there, to use that as a way
- 11:08Speaker 1: of putting out you know, getting resumes in and out
- 11:11Speaker 1: UM and trying to tap into kind of that younger set.
- 11:14Speaker 1: So that's one. The other thing that we're I found
- 11:16Speaker 1: very interesting is that they're actually offering signing bonuses. Some
- 11:20Speaker 1: brands are offering signing bonuses UM to get people in.
- 11:24Speaker 1: So it's it's we'll start to see some shifts there.
- 11:28Speaker 1: But for the most part, specifically when it comes to
- 11:31Speaker 1: labor and restaurants, UM, they are still challenged. We're seeing
- 11:36Speaker 1: that with kind of reduced menu offerings, reduced operating hours, etcetera. Uh,
- 11:42Speaker 1: and so they have to be creative today. I think
- 11:46Speaker 1: some of the retailers are pretty creative during this pandemic.
- 11:48Speaker 1: One of them was this curbside pickup. That's a pretty
- 11:50Speaker 1: cool thing. I kind of enjoy that. Is that going
- 11:53Speaker 1: to state? Do you think? Oh? Most definitely. We're actually
- 11:57Speaker 1: starting to see um, you know, letters of intent requesting
- 12:02Speaker 1: or requiring curbside pick up. So when I was speaking
- 12:06Speaker 1: with a variety of national retailers, I said, how is
- 12:09Speaker 1: that you helped or not helped having curbside? Is it
- 12:13Speaker 1: an added expense? They said, not at all. It's actually
- 12:16Speaker 1: a convenience to our customer. And it's another channel of
- 12:20Speaker 1: how we can um provide another solution for that that
- 12:24Speaker 1: customer where if they don't feel like they want to
- 12:26Speaker 1: come into the store and they just want to pick
- 12:28Speaker 1: it up curbside, they have that flexibility and so that's
- 12:31Speaker 1: really important to them. They've seen a lift in sales
- 12:34Speaker 1: anywhere between twelve and FI. Yeah, that's pretty pretty interesting
- 12:39Speaker 1: seeing retailers get pretty creative on j Slanki, national director
- 12:42Speaker 1: Retail for in the US for Collier's International, giving us
- 12:46Speaker 1: her thoughts on the retail landscape again generally pretty strong
- 12:50Speaker 1: as consumer confidence continues to rebound. All right, So we
- 12:55Speaker 1: are getting right into the meat of this earning season
- 12:58Speaker 1: and there's a lot of folks out there. It's a boy,
- 13:00Speaker 1: these earnings are really better come through because when you
- 13:02Speaker 1: look at valuations, you can make the argument that a
- 13:05Speaker 1: lot of these uh parts of the market are overextended
- 13:08Speaker 1: from evaluation perspective. Josh Wine, portfolio manager at Hennessey Funds,
- 13:12Speaker 1: joins as Josh, I love to get your thoughts on
- 13:14Speaker 1: kind of what you need to see, what you expect
- 13:17Speaker 1: to see out of this earnings season here as it
- 13:21Speaker 1: relates to you know, kind of maybe earnings and valuations
- 13:24Speaker 1: in this market. Yeah, it's good to be with you.
- 13:27Speaker 1: I have a spell in my face hearing about karaoke
- 13:29Speaker 1: and Dolly part and that's a great way to start
- 13:31Speaker 1: this out. The world is a better place for my
- 13:33Speaker 1: not doing karaoke as well. Um yeah, earning season, uh,
- 13:37Speaker 1: you know, certainly want to see the consumer so as
- 13:39Speaker 1: as companies roll out earnings. You know, it was very
- 13:41Speaker 1: interesting to see bank earnings and I think it was expected,
- 13:44Speaker 1: you know, very strong earnings there. But you know, we
- 13:46Speaker 1: have a retail sales number today that was well ahead
- 13:49Speaker 1: of expectations, and things like clothing and electronics and restaurants
- 13:53Speaker 1: were you know, above above average growth and and ahead
- 13:56Speaker 1: of expectations. So you know, it is what it is,
- 13:59Speaker 1: and it would be great to hear, you know, some guidance.
- 14:01Speaker 1: You know, what are you know, companies thinking about, you know,
- 14:04Speaker 1: the next quarter. You know, right now we have very
- 14:06Speaker 1: easy comparisons to a year ago. But you know, let's see,
- 14:09Speaker 1: you know, what it's going to look like in Q
- 14:11Speaker 1: four when the comparison is is meaningfully more difficult, and
- 14:15Speaker 1: certainly Q one of next year it will be somewhat
- 14:18Speaker 1: of a regular comparison to Q one of this year. Josh,
- 14:22Speaker 1: how are you investing in this time when you get
- 14:25Speaker 1: strong retail sales but then you see consumer sentiment coming
- 14:28Speaker 1: really soft given one year inflation expectations are going back
- 14:33Speaker 1: the highest since two thousand and eight. How do you
- 14:36Speaker 1: take to contradicting factors and invest Yeah, it's interesting because
- 14:41Speaker 1: you know, I was looking, you know, the market, you know,
- 14:44Speaker 1: twenty times forward earnings, so about a five percent earnings
- 14:47Speaker 1: yield against the backdrop of a one three on the tenure.
- 14:50Speaker 1: So you know, valuations on average are incredibly compelling. You
- 14:55Speaker 1: know that they're basically that's spread the earnings yield versus
- 14:59Speaker 1: the ten years were we were before the pandemic started. Uh.
- 15:02Speaker 1: That being said, you know, yeah, certainly size matters a
- 15:07Speaker 1: lot in this market increasingly so. So you know, a Microsoft,
- 15:11Speaker 1: great company, thirty four times forward earnings. When I see that,
- 15:15Speaker 1: and they're growing quite nicely, but I think to myself
- 15:18Speaker 1: that the market definitely places a premium on growth. I
- 15:21Speaker 1: think more so in the case of a Microsoft, it's
- 15:24Speaker 1: not only a great balance, but just the size and
- 15:26Speaker 1: the liquidity. So I think that there's definitely a size
- 15:29Speaker 1: and liquidity story, and what gets blocked out by that
- 15:33Speaker 1: by that sun is you know, kind of midcaps with
- 15:36Speaker 1: a similar valuation story and you know, compelling growth, but
- 15:41Speaker 1: certainly the multiples are not there, and I think that
- 15:44Speaker 1: you know in that lies you know a great opportunity. Josh,
- 15:47Speaker 1: where are you and your team at Hennessey Advisors in
- 15:51Speaker 1: Chapel Hill, North Carolina. I don't know why you didn't
- 15:54Speaker 1: locate in Durham Superior University down there, but anyway, what
- 15:58Speaker 1: are you and your team doing in terms of work
- 16:01Speaker 1: right now? What are the areas you're focusing on? Sure? Yeah,
- 16:04Speaker 1: so I would point you know, in our Hennessy Cornerstone
- 16:06Speaker 1: mad Cap thirty fund, where we're looking at valuation, earnings,
- 16:09Speaker 1: growth and stock price momentum. And where that leads us
- 16:13Speaker 1: is a lot of the consumer names that you know,
- 16:15Speaker 1: don't get the attention of of you know, maybe like
- 16:17Speaker 1: a Costco or a Starbucks. You know, these are MidCap names,
- 16:20Speaker 1: UH companies like Mattel, Big Lots UH and Meritage Homes,
- 16:26Speaker 1: so you know, strong free cash flow generating companies, you know,
- 16:30Speaker 1: strong balance sheets. The multiples are interesting to me because
- 16:33Speaker 1: I think these are for the most part well known names.
- 16:36Speaker 1: But you know, Big Lots trading at nine times for earnings,
- 16:39Speaker 1: Mattel at sixteen times, Meritage at about six times for earnings. So, uh,
- 16:45Speaker 1: you know, I think that that you know, value can
- 16:48Speaker 1: be its own catalyst. And and I don't think a
- 16:51Speaker 1: lot of people agree with that, but I think that
- 16:53Speaker 1: these names, they are strong names, and they will live
- 16:56Speaker 1: to see another day and and at some point investors
- 16:59Speaker 1: will inevitable a U turn their attention towards these overlooked
- 17:03Speaker 1: type names. What is the path forward for interest rates? It?
- 17:09Speaker 1: Does it have to go higher from here? How are
- 17:11Speaker 1: you thinking about that? Yeah? I think about it a lot.
- 17:15Speaker 1: So I've covered equities in in some way, shape or
- 17:18Speaker 1: form for about twenty five years, and I've never paid
- 17:21Speaker 1: that much attention to the bondo market as much as
- 17:23Speaker 1: I do now. And first of all, you know, the
- 17:25Speaker 1: bond market to me, you know, there might be some
- 17:28Speaker 1: Obviously the FED is gets in the way of maybe
- 17:31Speaker 1: true price discovery to a large degree, but the bond
- 17:34Speaker 1: market is telling me that maybe we are borrowing some
- 17:37Speaker 1: growth from future quarters now that we've reopened, and there's
- 17:40Speaker 1: this delayed wealth effects, so people are out spending money,
- 17:43Speaker 1: and uh, you know, you see that if you just
- 17:46Speaker 1: walk down any and he needs, you know, any street
- 17:48Speaker 1: in this country probably, And uh so, I think that
- 17:53Speaker 1: we've been saying for so many years now that rates
- 17:56Speaker 1: have to go higher, and every year that becomes less
- 18:00Speaker 1: and less true, and and so yeah, I don't think
- 18:02Speaker 1: they have to go higher. I think rates, you know,
- 18:05Speaker 1: versus overseas rates are are somewhat elevated in the United States.
- 18:09Speaker 1: And when I look at overseas markets and economies they
- 18:12Speaker 1: are in no, they are not nearly as good a
- 18:15Speaker 1: shape as we are here in the United States for
- 18:17Speaker 1: the most part. So I think that we have a
- 18:20Speaker 1: lot to contend with overseas and in emerging markets, and
- 18:23Speaker 1: I don't know how sustainable things could ever be if
- 18:26Speaker 1: we don't get those economies reopened and functioning properly. So
- 18:31Speaker 1: you know, I'm not going to make any prediction on
- 18:33Speaker 1: the tenure or bonds in general, but you know, I
- 18:36Speaker 1: don't think rates have to go higher at all, and
- 18:38Speaker 1: I think they could go a little bit lower. All right, Josh,
- 18:40Speaker 1: thank you so much. We appreciate that. As always Josh
- 18:43Speaker 1: Way and he's a portfolio manager at Tennessee Funds giving
- 18:45Speaker 1: us his thoughts on the market. Uh. Here it remains
- 18:49Speaker 1: bullish here, but earnings coming in fast and furious will
- 18:52Speaker 1: continue next week. We had the banks this week, as
- 18:55Speaker 1: Josh mentioned, coming in pretty starn solid. But we're gonna
- 18:58Speaker 1: have some tech. We're gonna have some consumer names next
- 19:00Speaker 1: week that will continue the narrative on earnings and this market.
- 19:04Speaker 1: This is Bloomberg looking at Moderna here stock is up
- 19:10Speaker 1: nine point eight percent all time high four dollars. Uh
- 19:14Speaker 1: it's got sporting a market cap of a hundred and
- 19:17Speaker 1: fourteen billion dollars included today in the SMP five hundred,
- 19:21Speaker 1: of course, manufacturer of the Moderna vaccine, which has been
- 19:25Speaker 1: so successful for so many patients for this COVID. Let's
- 19:28Speaker 1: get a sense of what's going on at this company.
- 19:30Speaker 1: That's now you probably started the you know, two years ago,
- 19:34Speaker 1: nobody really knew about it. Now it's a household name.
- 19:37Speaker 1: John Murphy, he's a pharmaceutical analyst for Bloomberg Intelligence based
- 19:40Speaker 1: in London. He joins us, John, tell us about this company.
- 19:43Speaker 1: Give us a thirty thou foot overview of what this
- 19:46Speaker 1: company really is. We know it, as you know, a
- 19:49Speaker 1: manufacturer of a very effective vaccine. But give us a
- 19:52Speaker 1: sense of what this company is about. Sure, yeah, nice
- 19:55Speaker 1: to join you. Actually you summed it up very nice.
- 19:57Speaker 1: That we hadn't really heard about this company, had we
- 19:59Speaker 1: a couple of years ago. Now it has been around since,
- 20:03Speaker 1: but only came to the market in two thousand and eighteen,
- 20:05Speaker 1: and it was a I guess a bit of a
- 20:07Speaker 1: minnow then, although at the time it created a splash
- 20:10Speaker 1: because it's i p O was seven and a half billion,
- 20:12Speaker 1: so for a biotech that that was quite significant. So
- 20:16Speaker 1: M R and A based a vaccine focused looking at
- 20:19Speaker 1: a number of different infectious diseases. You could argue they
- 20:23Speaker 1: maybe got a little bit lucky or got a big
- 20:25Speaker 1: leg up when COVID came along, because clearly there was
- 20:27Speaker 1: a lot of cash that that came their way. But
- 20:29Speaker 1: they have for for a number of years been looking
- 20:32Speaker 1: at areas such as flu rs V, side of megalovirus,
- 20:36Speaker 1: so really looking to to develop a broad pipeline of
- 20:41Speaker 1: of vaccines in the anti infective space. And again, as
- 20:44Speaker 1: I said, they clearly benefited from COVID here in terms
- 20:48Speaker 1: of getting an acceleration in development. And I guess the
- 20:51Speaker 1: question now is after COVID, where do things go? That
- 20:54Speaker 1: is the question. What is the future for this company.
- 20:56Speaker 1: We had a great conversation earlier this week talking about
- 20:59Speaker 1: using at m R and a technology for cancer for HIV.
- 21:03Speaker 1: I mean, the hopes here are so high. Yeah, I
- 21:06Speaker 1: think you're exactly right now. And and you know what,
- 21:09Speaker 1: sometimes I think, um, and it's kind of natural that
- 21:12Speaker 1: when you see a new technology, expectations initially are high,
- 21:16Speaker 1: they get they then they get a little bit disappointed,
- 21:19Speaker 1: if you like, when when these high expectations aren't met.
- 21:21Speaker 1: And now we're kind of going up to that to
- 21:23Speaker 1: that peak again. So I think if you look at
- 21:25Speaker 1: the anti infective areas again, as I mentioned the lights
- 21:28Speaker 1: of flu, rs V, sites of megalovirus, these are probably
- 21:31Speaker 1: more realistic in the next three to five years to
- 21:34Speaker 1: see them come out with a product. I'm pretty long
- 21:37Speaker 1: in the tooth, and I can tell you twenty years
- 21:39Speaker 1: ago we were talking about cancer vaccines. We've not seen
- 21:42Speaker 1: them come through. I wouldn't be betting my money on
- 21:45Speaker 1: on cancer delivering something there. HIV again looks like a
- 21:49Speaker 1: pretty difficult area. But although maybe not not as not
- 21:52Speaker 1: a sexy, not as attractive rs V side of megalovirus,
- 21:56Speaker 1: these are five to ten billion dollar markets, so it's
- 21:59Speaker 1: a very very large from that perspective. All right, I'd
- 22:02Speaker 1: love to talk about the economics of the vaccine. I'm
- 22:05Speaker 1: looking at the f A function on the Bloomberg terminal,
- 22:07Speaker 1: which gives the income statement balance you all the good
- 22:09Speaker 1: stuff you would need for financial analysis on m r
- 22:13Speaker 1: n A, which is the MODERNA symbol. Eight hundred million
- 22:16Speaker 1: dollars in revenue in analysts estimate eighteen point six billion.
- 22:23Speaker 1: Is all of that the vaccine. Talked to us about
- 22:25Speaker 1: the economics for MODERNA of this vaccine. They're not given
- 22:28Speaker 1: it away, are they? It is all the vaccine. Yeah,
- 22:32Speaker 1: that that is essentially that is essentially a pent You're
- 22:35Speaker 1: absolutely that is the vaccine. And I think the big
- 22:38Speaker 1: question as well, because as you said in your introduction,
- 22:41Speaker 1: you've got you've got to stop. Here is a hundred
- 22:43Speaker 1: and fourteen hundred and fifteen billion dollar market cat what
- 22:46Speaker 1: is the sustainability of that income? So can we factor
- 22:49Speaker 1: into our numbers what it's going to do. Is it're
- 22:51Speaker 1: gonna do twenty billion again next year for example, give
- 22:54Speaker 1: or take the company says it can do, and then
- 22:56Speaker 1: what happens in a couple of years after that in
- 22:59Speaker 1: terms of in the to the actual the actual economics.
- 23:03Speaker 1: They don't release or tell you exactly what they're charging,
- 23:06Speaker 1: but you can estimate it's a shop here. Um. And
- 23:10Speaker 1: of course they're going to have some associated costs marketing costs,
- 23:13Speaker 1: they've got the R and D costs. But it's going
- 23:15Speaker 1: to be relatively profitable for them in the high income markets, certainly,
- 23:19Speaker 1: But like a lot of a lot of their competitors,
- 23:22Speaker 1: this is being provided at cost to the low income markets.
- 23:24Speaker 1: And Kovacs for example. You know, John, I'm smart enough
- 23:28Speaker 1: to know that I should not be going toe to
- 23:30Speaker 1: toe with Mr Paul Sweeney on level two income statement
- 23:33Speaker 1: analysis for the c f A. What I can ask you, though,
- 23:37Speaker 1: is take us away a little bit from fundamentals, and
- 23:40Speaker 1: you have a stock that's now included in the S
- 23:42Speaker 1: and P five hundred. What are you hearing from We
- 23:46Speaker 1: know their portfolios that track the S and P that
- 23:50Speaker 1: now have to buy the stock. How much of that
- 23:52Speaker 1: is also included in a move that's now up ten
- 23:55Speaker 1: on the day. Yeah, Now, I think I think you're
- 23:58Speaker 1: exactly right, and I think that's exactly what it should
- 24:01Speaker 1: be linked to today's move. I think we've seen it before,
- 24:04Speaker 1: because you get the fact that there's a number of
- 24:06Speaker 1: index passive funds. You've also got mutual funds, for example,
- 24:10Speaker 1: that index themselves against the SMP. And you guys have
- 24:13Speaker 1: no better than me. But I understand there's in excess
- 24:15Speaker 1: of ten trillion dollars that is index or benchmark to
- 24:19Speaker 1: the SMP. Now, not all of those have to go
- 24:21Speaker 1: out and buy the stock today. But again we've seen
- 24:24Speaker 1: it before. You get a spike for the first couple
- 24:26Speaker 1: of days, and then it normally settles down. Maybe with
- 24:29Speaker 1: Maderna because we've had this phenomenal run, maybe it doesn't
- 24:31Speaker 1: settle down as quickly, but that's what you that's certainly
- 24:34Speaker 1: what you do. Tend tend to see m r N
- 24:37Speaker 1: a technology that's now entered the lexicon for a lot
- 24:40Speaker 1: of people as we've kind of dealt through this pandemic.
- 24:44Speaker 1: Give us a sense of who the players are here
- 24:46Speaker 1: besides moderna And you know, is this is this something
- 24:49Speaker 1: that we need to pay attention to going forward, this technology? Yes,
- 24:54Speaker 1: I think that's a really important question, a great point
- 24:56Speaker 1: to bring up, and and the reason for that is
- 24:59Speaker 1: the was a lot of talk about this. There's a
- 25:01Speaker 1: lot of buzzwords go around in pharmaceuticals, in science, and
- 25:05Speaker 1: they talk about new technologies and what they're going to deliver,
- 25:08Speaker 1: and a lot of times there's a lot of a
- 25:10Speaker 1: lot of talk, but they don't tend to deliver. Now,
- 25:12Speaker 1: now this is absolutely not the case here. But we've
- 25:15Speaker 1: really got two leaders here. We've got Maderna on one side,
- 25:18Speaker 1: and we've got by on Tech, the German company with
- 25:21Speaker 1: whom Fiser is partnered. They're the two leaders. They're a
- 25:25Speaker 1: long way out, and it's interesting. There's a lot of
- 25:27Speaker 1: others and making moves or saying we want to get involved.
- 25:31Speaker 1: Fiser themselves that said they might start up their own
- 25:33Speaker 1: their own area. Glaxo had mentioned that, Santa Fe had
- 25:36Speaker 1: mentioned it, but it takes a number of years to
- 25:39Speaker 1: really get get to understand the technology and make the
- 25:42Speaker 1: appropriate investments. So at the moment these guys are out
- 25:45Speaker 1: on their own, how much of a lead, maybe four
- 25:48Speaker 1: to five years of the lead something like that. But
- 25:50Speaker 1: but clearly it's an area that is going to be
- 25:53Speaker 1: super important going forward for vaccines. Finally, just quickly here,
- 25:58Speaker 1: I'm thinking, what does this means? Are other sort of
- 26:00Speaker 1: biotech companies that are also racing along with Maderna and
- 26:04Speaker 1: and you sort of have these big pharmaceutical companies that
- 26:07Speaker 1: are making big bats on some of these unprofitable companies
- 26:10Speaker 1: at the time. But all they need is is one
- 26:13Speaker 1: big grand slam. Yeah, I'm a guess, and you know,
- 26:17Speaker 1: the drug companies, the investors, all of us, right, if
- 26:19Speaker 1: we're looking at things like that, if you can, if
- 26:21Speaker 1: you can pick out, pick out that grand slam. Absolutely,
- 26:24Speaker 1: and that's why a lot of companies are paying huge
- 26:27Speaker 1: amounts and some some cases people would say over paying
- 26:30Speaker 1: for the new technologies. It's not easy to be able
- 26:34Speaker 1: to pick out unfortunately. So I think this is great
- 26:37Speaker 1: for the sector going in today. It gets people to
- 26:39Speaker 1: focus on a sector that maybe they've not looked at before. Hey, John,
- 26:43Speaker 1: thanks so much for joining us. Really appreciate your insight
- 26:45Speaker 1: and expertise. John Murphy's a pharmaceutical analysts for Bloomberg Intelligence
- 26:49Speaker 1: based in London, giving us the latest on moderna. This
- 26:53Speaker 1: is Bloomberg. Thanks for listening to the Bloomberg Markets podcast.
- 26:57Speaker 1: You can subscribe and listen to interviews with Apple Podcasts
- 27:00Speaker 1: or whatever podcast platform you prefer. I'm Matt Miller. I'm
- 27:04Speaker 1: on Twitter at Matt Miller three and I fall Sweeney.
- 27:08Speaker 1: I'm on Twitter at pt Sweeney. Before the podcast, you
- 27:10Speaker 1: can always catch us worldwide at Bloomberg Radio